Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cancer Risk Equipment Supplied In Europe
12 equipment items found
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
Manufactured by:MD Diagnostics Ltd based inChatham, UNITED KINGDOM
Dental professionals have a unique opportunity to address smoking with patients in a manner that will make a difference. Brief advice from a dentist or member of the dental team has been shown to increase a patient’s motivation to quit and can double a patient’s success with ...
Manufactured by:Newmars Technologies Ltd. based inBudapest, HUNGARY
Cervical Cancer is the 2nd most common cancer afflicting women worldwide [1]. In many countries, cervical cancer screening programs utilize a Pap test. If the Pap result is abnormal a visual examination called colposcopy, and in many instances one or more biopsies of the cervix is preformed to detect abnormal cervical tissue. Recently, physicians have started to include a Human papillomavirus ...
Manufactured by:ORYX GmbH & Co. KG based inBaldham, GERMANY
The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate senescence. In all cancers associated with high risk human papilloma virus (HR-HPV), p16INK4a is constantly expressed as an ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for their patients. ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The QIAsure Methylation Test is a multiplex real-time methylation specific PCR-based (qMSP) assay that detects hyper methylation of 2 disease related marker genes, FAM19A4 and mir124-2, to distinguish women with cervical (pre)cancer. The test specifically detects women with a cancer-like methylation profile, which are indicative for the women who have a ...
Manufactured by:CTIBiotech based inMeyzieu, FRANCE
Although much is known about the appearance, growth and spread of cancer in the human body, effective and rapid treatments for many cancer types are yet to be found. Chemo- and radio- therapies have made much progress in the last 20 years, but many such therapies are non-specific, leaving the patient to deal with severe side effects of the therapy and organ damage through cancer cell ...
Manufactured by:Amadix based inValladolid, SPAIN
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of individuals with Lung ...
Manufactured by:Therawis based inMunich, GERMANY
Personalized medicine aims to identify patients who require treatment and subsequently select the right therapy based on individual factors and tumor characteristics, i.e. personalized medicine targets to identify the right patients for the right therapy. Prognostic biomarkers provide information on the risk of disease recurrence whereby predictive ones will inform the physician ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
MDxHealth’s technology platform is called methylation-specific PCR (MSP), which is a proprietary DNA-based technology that functions on standard commercial PCR equipment. MSP is extremely powerful and accurate with the ability to detect a single cancer cell among 10,000 healthy cells in any type of bodily fluid or tissue. MDxHealth has patents and other intellectual property on the MSP ...
Manufactured by:Neosys Surgical Solutions Ltd. based inAnkara, TURKEY
Glucosamine is one of the most common supplements that people get when they have joint pain. In support, it is usually taken in the form of glucosamine sulfate, in combination with ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the ...